Elrexfio Injection, Solution
Product Images NDC 0069-2522

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Elrexfio (NDC 0069-2522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Logo (Elranatamab 01)

Logo (Elranatamab 01)
Pfizer Labs, a division of Pfizer Inc., headquartered in New York, NY 10001, is the distributor of the product.*
FDA Label Image

Logo (Elranatamab 02)

Logo (Elranatamab 02)
Pfizer Labs, a division of Pfizer Inc., located in New York, NY 10001, is the distributor of the product.*
FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)
FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)

Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)
Not available*
FDA Label Image

Principal Display Panel – 76 mg/1.9 mL Vial (Elranatamab 05)

Principal Display Panel – 76 mg/1.9 mL Vial (Elranatamab 05)
FDA Label Image

Principal Display Panel – 76 mg/1.9 mL Vial Carton (Elranatamab 06)

Principal Display Panel – 76 mg/1.9 mL Vial Carton (Elranatamab 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.